Dokkyo Medical University · Faculty of Medicine

Research keywordstype 2 diabetes・glycemic variability・GLP 1 receptor・empagliflozin・diabetic neuropathy・hyperglycemia management

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Impact of inpatient management of hyperglycemia on peripheral T cell markers in patients with type 2 diabetes., Kunii Tomohisa;Usui Isao;Jojima Teruo;Shimizu Masanori;Kase Masato;Sakurai Shintaro;Tomaru Takuya;Iijima Toshie;Aso Yoshimasa, Diabetology international, 15（3）, 414-420, 2024年02月26日2024 · 論文
• Empagliflozin increases plasma levels of citrulline, histidine, and α-aminobutyric acid in patients with type 2 diabetes: effects of a sodium-glucose co-transporter 2 inhibitor on the plasma amino acid profile., Jojima Teruo;Sakurai Shintaro;Kishi Haruka;Kato Kananko;Iijima Toshie;Tomaru Takuya;Usui Isao;Aso Yoshimasa, Expert opinion on pharmacotherapy, 25（7）, 937-944, 2024年06月04日2024 · 論文
• Diabetes with GLP-1R polymorphism (rs3765467) accompanied by myotonic dystrophy: A case of myotonic dystrophy with p.R131Q polymorphism at the glucagon-like peptide-1 receptor (rs3765467) resulting in marked effects of its agonist, dulaglutide., Kato Kanako;Jojima Teruo;Kogai Takahiko;Tanuma Dai;Niitani Takafumi;Sakurai Shintaro;Iijima Toshie;Tomaru Takuya;Usui Isao;Aso Yoshimasa, The American journal of the medical sciences, 369（1）, 126-130, 2024年07月08日2024 · 論文
• Acute Effect of Imeglimin Add-on Therapy on 24-h Glucose Profile and Glycemic Variability in Patients with Type 2 Diabetes Receiving Metformin., Shinohara Yasutake;Jojima Teruo;Kamiga Yusuke;Sakurai Shintaro;Iijima Toshie;Tomaru Takuya;Akutsu Ikuo;Inoue Teruo;Usui Isao;Aso Yoshimasa, Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 33（6）, 569-577, 2024年08月12日2024 · 論文

• Official profile